Arama Sonuçları - Per Pfeiffer

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first? Yazar: Per Pfeiffer, Thomas Gruenberger, Robert Glynne-Jones

Tam Metin Erişim

How to select cancer patients for immunotherapy Yazar: Per Pfeiffer, Camilla Qvortrup, Karin Holmskov Hansen

Tam Metin Erişim

Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review Yazar: Magnus Ploug, Martin Graversen, Per Pfeiffer, Michael Bau Mortensen

Tam Metin Erişim

Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I–III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II... Yazar: Ismail Gögenur, Per Pfeiffer, Tobias Freyberg Justesen, Line Schmidt Tarpgaard, Camilla Qvortrup

Tam Metin Erişim

Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis Yazar: Takayuki Yoshino, Julien Taieb, Yasutoshi Kuboki, Per Pfeiffer, Amit Kumar, Howard S. Hochster

Tam Metin Erişim

Prevalence and management of immediate drug hypersensitivity observed during antineoplastic drug therapy Yazar: Trine Holm Rasmussen, Charlotte Gotthard Mortz, Per Pfeiffer, Nina Andersen, Carsten Bindslev-Jensen

Tam Metin Erişim

Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis Yazar: Martin Graversen, Sönke Detlefsen, Jon Kroll Bjerregaard, Claus Wilki Fristrup, Per Pfeiffer, Michael Bau Mortensen

Tam Metin Erişim

Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials Yazar: Mathilde Weisz Ejlsmark, Tine Schytte, Uffe Bernchou, Rana Bahij, Britta Weber, Michael Bau Mortensen, Per Pfeiffer

Tam Metin Erişim

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer. Yazar: Christina Siesing, Halfdan Sorbye, Anca Dragomir, Per Pfeiffer, Camilla Qvortrup, Fredrik Pontén, Karin Jirström, Bengt Glimelius, Jakob Eberhard

Tam Metin Erişim

A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study Yazar: Martina Eriksen, Per Pfeiffer, Kristoffer Staal Rohrberg, Christina Westmose Yde, Lone Nørgård Petersen, Laurids Østergaard Poulsen, Camilla Qvortrup

Tam Metin Erişim

TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trialResearch in context Yazar: Lene Baeksgaard Jensen, Mette Yilmaz, Marianne Nordsmark, Sören Möller, Ida Coordt Elle, Morten Ladekarl, Camilla Qvortrup, Per Pfeiffer

Tam Metin Erişim

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors Yazar: Rikke Løvendahl Eefsen, Jan Stenvang, Jiri Bartek, Per Pfeiffer, Line Tarpgaard, Susann Theile, Nils Brünner, Dorte L. Nielsen

Tam Metin Erişim

Prediction of overall survival in patients with locally advanced pancreatic cancer using longitudinal diffusion-weighted MRI Yazar: Anne L. H. Bisgaard, Anne L. H. Bisgaard, Carsten Brink, Carsten Brink, Tine Schytte, Tine Schytte, Rana Bahij, Mathilde Weisz Ejlsmark, Mathilde Weisz Ejlsmark, Uffe Bernchou, Uffe Bernchou, Anders S. Bertelsen, Anders S. Bertelsen, Per Pfeiffer, Per Pfeiffer, Faisal Mahmood, Faisal Mahmood

Tam Metin Erişim

Characteristics, treatment, and outcome of recurrent gastro-oesophageal adeno­carcinoma after perioperative chemotherapy and radical resection Yazar: Anders Christian Larsen, Susy Shim, Lene Bæksgaard, Per Pfeiffer, Marianne Nordsmark, Jan Reiter Sørensen, Rasmus Brøndum, Anne Krejbjerg Motavaf, Morten Ladekarl

Tam Metin Erişim

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy f... Yazar: Stine Braendegaard Winther, Pia Österlund, Åke Berglund, Bengt Glimelius, Camilla Qvortrup, Halfdan Sorbye, Per Pfeiffer, - on behalf of the Academy of Geriatric Cancer Research (AgeCare)

Tam Metin Erişim

Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer Yazar: Karen-Lise Garm Spindler, Christina Demuth, Boe Sandahl Sorensen, Julia S Johansen, Dorte Nielsen, Niels Pallisgaard, Estrid Hoegdall, Per Pfeiffer, Benny Vittrup Jensen

Tam Metin Erişim

Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients Yazar: Kristine Ø. Aasebø, Anca Dragomir, Magnus Sundström, Artur Mezheyeuski, Per‐Henrik Edqvist, Geir Egil Eide, Fredrik Ponten, Per Pfeiffer, Bengt Glimelius, Halfdan Sorbye

Tam Metin Erişim

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Met... Yazar: Halfdan Sorbye, Anca Dragomir, Magnus Sundström, Per Pfeiffer, Ulf Thunberg, Monica Bergfors, Kristine Aasebø, Geir Egil Eide, Fredrik Ponten, Camilla Qvortrup, Bengt Glimelius

Tam Metin Erişim

Implementation of Rapid Drug Desensitization in Antineoplastic Drug Therapy in Denmark Using One‐Bag Protocols Yazar: Trine Holm Rasmussen, Charlotte Gotthard Mortz, Per Pfeiffer, Nina Andersen, David George Mawn, Line Kring Tannert, Millie Nguyen Basu, Helene Marlies Rasmussen, Carsten Bindslev‐Jensen

Tam Metin Erişim

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan. Yazar: Jakob V Schou, Simona Rossi, Benny V Jensen, Dorte L Nielsen, Per Pfeiffer, Estrid Høgdall, Mette Yilmaz, Sabine Tejpar, Mauro Delorenzi, Mogens Kruhøffer, Julia S Johansen

Tam Metin Erişim